Litcius/Paper detail

Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial

Edmund Tsui, Sivakumar R. Rathinam, John A. Gonzales, Radhika Thundikandy, Anuradha Kanakath, S. Balamurugan, Rajesh Vedhanayaki, Lyndell L. Lim, Eric B. Suhler, Hassan Al-Dhibi, Thuy Doan, Jeremy D. Keenan, Caleb D. Ebert, Eric H. Kim, Brian Madow, Travis C. Porco, Nisha R. Acharya

2022Ophthalmology18 citationsDOI

Topics & Concepts

MedicineUveitisVisual acuityMethotrexateMacular edemaInterquartile rangeRandomized controlled trialSurgeryClinical endpointPrednisoneOphthalmologyOcular Diseases and Behçet’s SyndromeCNS Lymphoma Diagnosis and TreatmentIgG4-Related and Inflammatory Diseases
Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial | Litcius